Walgreens Boots Alliance, Inc. which can be found using ticker (WBA) now have 13 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The range between the high target price and low target price is between 45 and 26 suggesting an average Analsyt target price of $32.31. Now with the previous closing price of $22.19 this is indicating there is a potential upside of 45.6%. It’s also worth noting that there is a 50 day moving average of $27.15 and the 200 day moving average is $32.79. The market cap for the company is 19.16B. The stock price is currently at: 22.03 USD
The potential market cap would be $27,891,974,200 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 157.64 and a 0.67% return on assets.
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The Company’s U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. Its International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. Its portfolio of consumer brands include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
